BILLERICA, Mass. — Access Vascular, Inc. (AVI), a medical device company specializing in developing advanced vascular access solutions, today announced its HydroMID® midline catheter has received an Innovative Technology contract from Vizient®, the nation’s largest provider-driven healthcare performance improvement company. The contract was awarded based on review of the HydroMID® device from hospital experts who serve on one of Vizient’s client-led councils, and it signifies to Vizient clients its unique qualities that potentially bring improvement to the healthcare industry.
Innovative Technology contracts are awarded following a thorough evaluation of products submitted through Vizient’s Innovative Technology Program. Vizient client-led councils identify technologies that have the potential to enhance clinical care, patient safety, healthcare worker safety or improve business operations of healthcare organizations.
AVI’s HydroMID® catheters feature a proprietary hydrogel material to help address catheter-related complications such as thrombosis and occlusion – potential sources of morbidity, readmissions, and cost for health systems. The U.S. Food & Drug Administration (FDA) cleared a new anti-thrombogenic indication for HydroMID® in 2025.